Skip Navigation LinksHome > Professional Development > AABB Zika Virus Symposium: Blood & HCT/P Safety On-Demand Synced Presentations

AABB Zika Virus Symposium: Blood & HCT/P Safety On-Demand Synced Presentations

Select Presentations from the 2016 Zika Virus Symposium

 

Includes select synced presentations and corresponding handouts. Check out the Zika Virus Symposium opening remarks presented by Richard Kaufman, MD.

Event Description

The US blood and HCT/P community is currently preparing for the potential of transfusion/transplantation–associated transmission of Zika virus. Both AABB and FDA have issued recommendations to minimize the risk of transmission of Zika virus through blood transfusion or transplantation of HCT/Ps. The symposium addressed approaches to preparedness while anticipating the emergence of mosquito-borne transmission of Zika virus in the US. Speakers also discussed current experiences with donor testing under IND, the use of pathogen inactivation and research initiatives.

Learning Objectives

At the end of the program, participants will be able to:

  • Discuss the implications for public health and blood and HCT/P safety as the US prepares for Zika virus and lessons learned from other arboviruses.
  • Provide an update to the status of investigational donor screening interventions for Zika virus and safety research initiatives.
  • Review current recommendations for the blood supply and for HCT/P’s.
Intended Audience

Physicians, Scientists, Executive Management, Technologists, Nurses, Managers/Supervisors

Teaching Level

Intermediate to Advanced

Presentation Fees

List Price: $250
Member Discount Price: $150
Individuals purchase online via the AABB Marketplace. Access will be granted via email within 48 hours of registration.

Presentations

Introduction

Rick Kaufman, MD
Medical Director, Brigham and Women’s Hospital Adult Transfusion Service
Associate Professor of Pathology, Harvard Medical School

FDA Recommendations on Assuring Blood Safety for ZIKA

Jay Epstein, MD
Director, Office of Blood Research and Review
Center for Biologics Evaluation and Research, Food and Drug Administration

Canadian Approach: HQ Risk Analysis

Marc Germain, MD, FRCP, PhD
Vice President, Medical Affairs
Hema-Quebec

FDA Recommendations and Analyses Supporting US HCT/P Safety

Michelle McClure, PhD
Division of Human Tissues
Office of Cellular, Tissue and Gene Therapies
Center for Biologics Evaluation and Research
Food and Drug Administration

Scott Koepsell, MD, PhD
Assistant Professor
University of Nebraska Medical Center
Assistant Professor, Department of Pathology and Microbiology
Medical Director, Division of Transfusion and Transplantation Services

State and Blood Center Approaches to Preparedness in the US

Danielle Stanek, DVM
FL DOH Division of Disease Control and Health Protection
Zoonotic and Vectorborne Disease Program Manager

David Gruber
Assistant Commissioner
Division for Regional and Local Health Services
Texas Department of State Health Services

Rita Reik, MD
Chief Medical Officer
OneBlood, Inc.

Susan Rossmann, MD, PhD
Chief Medical Officer
Gulf Coast Regional Blood Center

NAT Assay Development: Hologic

Jeff Linnen, PhD
Assoc.Vice President, Research & Development
Hologic, Inc.

Perspectives & Challenges Panel Discussion | Questions & Answers

Roger Dodd, PhD
Executive Scientific Officer
American Red Cross Holland Laboratory

Closing

Richard Kaufman, MD
Medical Director, Brigham and Women’s Hospital Adult Transfusion Service
Associate Professor of Pathology, Harvard Medical School

Continuing Education Credit

Physicians

AABB is an approved provider by the Accreditation Council on Continuing Medical Education (ACCME), to provide continuing medical education for physicians. AABB designates this activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

California Nurses

AABB is approved by the California Board of Registered Nursing as a provider of continuing nursing education activities. AABB designates this activity for a maximum of 4.0 contact hours.

California Clinical Laboratory Personnel

AABB is an approved accrediting agency for continuing education for California licensed clinical laboratory personnel. This event has been approved for a maximum of 3.5 contact hours. AABB’s accrediting agency number is 0011. Credit earned through participation at this activity may be used to fulfill the state requirement for continuing education hours to maintain licensure status.

Florida Clinical Laboratory Personnel

AABB is approved by the Florida Board of Clinical Laboratory Personnel, Provider Number 50-4261-1, as a provider of continuing education programs for Florida-licensed clinical laboratory personnel. This event has been approved for a maximum of 4.0 contact hours.

General Attendee

Administrators, laboratory personnel, nurses (non-California) and general attendees will receive a certificate of completion for participation in this activity.